Juta MedicalBrief·2 min read·medium

Better weight loss from bariatric surgery than Ozempic, Zepbound - US study

Better weight loss from bariatric surgery than Ozempic, Zepbound - US study
AI Summary

A new study published in Obesity suggests that bariatric surgery may provide more effective long-term weight loss results compared to GLP-1 medications like semaglutide and tirzepatide. Researchers clarify that these findings do not negate the value of GLP-1 drugs but offer a comparative perspective on treatment outcomes.

A real-world study recently published in Obesity found that bariatric surgery may confer greater long-term weight loss than semaglutide or tirzepatide for adults with obesity, with the researchers saying the findings “don’t argue against GLP-1s; they... [6215 chars]

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in